Clinical Trial Update: Intravitreal Dexamethasone Implant in Retinitis Pigmentosa-related Macular Edema- a Retrospective Study [Phase 2]

View source ↗

Summary

A retrospective Phase 2 study evaluating the use of dexamethasone intravitreal implant for macular edema associated with Retinitis Pigmentosa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystoid Macular Edema
• Retinitis Pigmentosa

Drugs mentioned

• Dexamethasone Intravitreal Implant (Ozurdex) (dexamethasone intravitreal implant)

Snippet

Sponsor: Rafic Hariri University Hospital | Conditions: Retinitis Pigmentosa, Cystoid Macular Edema | Phase 2 | Status: UNKNOWN